EMEA-000973-PIP01-10-M03
Key facts
| Invented name |
|
| Active substance |
Recombinant human N-acetylgalactosamine-6-sulfatase (BMN110)
|
| Therapeutic area |
Endocrinology-Gynaecology-Fertility-Metabolism
|
| Decision number |
P/0055/2015
|
| PIP number |
EMEA-000973-PIP01-10-M03
|
| Pharmaceutical form(s) |
Concentrate for solution for infusion
|
| Condition(s) / indication(s) |
Treatment of mucopolysaccharidosis, type IVA (Morquio-A syndrome)
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
BioMarin Europe Limited
|
| Decision type |
PM: decision on the application for modification of an agreed PIP
|